Form 4: Aura Biosciences Executive Receives Stock Grant
Insider Transaction (Form 4)
Amy Elazzouzi, SVP, Finance & PAO of Aura Biosciences, Inc., reported multiple transactions in common stock on September 1, 2026.
Summary
- Grant/award: acquired 23,540 Common Stock on September 1, 2026; holds 143,600 after (Direct).
- Grant/award: acquired 46,460 Stock Option (Right to Buy) on September 1, 2026; holds 46,460 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Amy Elazzouzi — Officer (SVP, Finance & PAO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Common Stock | 23,540 | — | — | 143,600 |
| 2026-09-01 | Grant/award | Stock Option (Right to Buy) | 46,460 | — | — | 46,460 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (23,540 shares) |
| 2026-09-01 | Grant/award (46,460 shares) |
Keywords
insider transaction, Form 4, AURA, Aura Biosciences, Inc., neutral, Amy Elazzouzi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.